4//SEC Filing
Gao Hanlin 4
Accession 0000950170-25-029435
CIK 0001674930other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 9:04 PM ET
Size
16.6 KB
Accession
0000950170-25-029435
Insider Transaction Report
Form 4
Gao Hanlin
Chief Scientific Officer
Transactions
- Award
Common Stock
2025-02-25+11,926→ 937,514 total - Award
Common Stock
2025-02-25+37,790→ 967,818 total - Award
Common Stock
2025-02-25+4,571→ 925,588 total - Tax Payment
Common Stock
2025-02-25$16.29/sh−1,211$19,727→ 936,303 total - Tax Payment
Common Stock
2025-02-25$16.29/sh−1,636$26,650→ 934,667 total - Award
Common Stock
2025-02-25+3,384→ 921,017 total - Tax Payment
Common Stock
2025-02-25$16.29/sh−4,639$75,569→ 930,028 total - Tax Payment
Common Stock
2025-02-26$16.24/sh−2,523$40,974→ 965,295 total
Footnotes (8)
- [F1]Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 28, 2022.
- [F2]Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 23, 2023.
- [F3]Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 26, 2024.
- [F4]The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 28, 2022.
- [F5]The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 23, 2023.
- [F6]The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 26, 2024.
- [F7]Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after March 1, 2025, and 1/12th of such shares vesting at the end of every three-month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date.
- [F8]The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024.
Documents
Issuer
Fulgent Genetics, Inc.
CIK 0001674930
Entity typeother
Related Parties
1- filerCIK 0001684532
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 9:04 PM ET
- Size
- 16.6 KB